Our people are at the heart of our mission to leave no person living with HIV behind. Through their dedication, passion, and commitment to making a difference, we can drive forward initiatives that contribute to ending the HIV epidemic. Across the entirety of our business, every action taken ladders up to the overarching goal of ensuring that every person affected by HIV receives the support and care they need to thrive.
We asked some of our employees the ultimate question – what will it take to end the HIV epidemic?
ROB'S STORY
Rob has dedicated his entire career to HIV science, from working on AZT during his internship days to now being part of ViiV’s Translational Research and HIV Cure team, continuing to push HIV science forward in pursuit of ending the HIV epidemic.
DAWN'S STORY
Dawn is a scientist in ViiV’s Discovery team. Driven by a natural curiosity to explore new things, she works across thousands of compounds to identify those with the potential to become life-changing medicines for people living with HIV.
JOE'S STORY
Coming from a family of pharmaceutical professionals, Joe began working in HIV in 1995 and is now helping to develop the next generation of HIV therapies, with the goal of empowering people living with HIV to live full and fulfilling lives.
PAUL'S STORY
Paul Benn is an Early Development Lead in our Research and Development team. He works alongside our scientists to help drive innovative ways to treat, prevent, and hopefully one day cure HIV.
AMA'S STORY
Ama is a part of our patient engagement team and is committed to ensuring that the voices of those living with and impacted by HIV are heard and amplified.
DARREN'S STORY
Darren A Brown works in our Medical Affairs team, helping ensure healthcare professionals have the right information to make informed decisions for the people they care for, enabling more person-centred care.
TREVOR'S STORY
Trevor Banthorpe joined ViiV in 2017 as part of our ‘back to work programme’ and now is a part of our Communications and Government affairs team, helping to ensure no person living with HIV is left behind.
HEWAN'S STORY
Hewan Wole is a global marketing director at ViiV who is working on medicines and innovations that will create ripple effects for generations to come.
NOEL'S STORY
Noel Watson-Doig is part of our legal team at ViiV, Noel is passionate about expanding access to HIV treatment and prevention through partnerships with global organisations such as the Medicines Patent Pool (MPP).
TINASHE'S STORY
Tinashe Rufurwadzo is a part of our Positive Action team. Passionate about HIV awareness and education, he plays a key role in ensuring we show up for the community in a unique way, amplifying their voices in everything that we do.
YOU MIGHT ALSO BE INTERESTED IN
HIV in View provides a platform for honest conversations around living with HIV and the stigma and discrimination that pervades.
In this article, Mercy Shibemba shares her hopes and aspirations for the future. She reflects on how living with HIV shaped her childhood and how her concept of healthy living may shift as she gets older.
The treatment and prevention of HIV has changed. With more options available than ever before, open and honest conversations between individuals and their healthcare professionals can help ensure people receive the best possible care for them.
NP-GBL-HVX-COCO-240022 September 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
